Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,356 INR | +4.03% | +5.33% | +0.17% |
05-24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
05-16 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.17% | 1.19B | |
+18.73% | 42.33B | |
+21.25% | 22.47B | |
+16.59% | 15.25B | |
+19.97% | 14.29B | |
+52.97% | 12.6B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.27% | 5.47B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q1 2023 Earnings Call, Aug 05, 2022